Nk Cell Therapy Clinical Trial

Clinical trials look at new ways to prevent detect or treat disease.

Nk cell therapy clinical trial.

8 10 1 chiossone l et al natural killer cells and other innate lymphoid cells in cancer. Allogeneic natural killer nk cells mg4101 were manufactured from normal healthy donor who underwent leukapheresis. After receiving these nk cells patients may also be given a drug called alt803. Using irradiated nk 92 cells the study was designed to watch for safety identify proper dosing levels and assess how effective the treatment was.

The natural killer cell platform is being investigated in multiple clinical trials across tumor sites. We re trying to build on the natural ability of nk cells by giving them the skills to recognize and destroy cancer cells that have made themselves invisible says katy rezvani m d ph d co leader of md anderson s adoptive cell therapy platform. Nk cells are a form of lymphocytes that defend against cancer cells. The initiation of this trial represents a significant milestone for our company marking the first clinical study of an allogeneic nk cell therapy generated using acepodia s proprietary acc technology sonny hsiao phd chief executive officer president and co founder of acepodia said in a press release.

Through clinical research md anderson is developing a new type of immunotherapy called car nk therapy. Clinical studies have shown that high doses of nk cells infused as an adoptive immunotherapy can reduce residual disease and strengthen the body s ability to fight cancer. Nci s basic information about clinical trials explains the types and phases of trials and how they are carried out. The natural killer cell platform consists of investigational agents that are restricted by federal law to investigational use only.

K nk003 a phase 1 study will begin in 2020 evaluating nk cells as a treatment for patients with relapse and refractory acute myeloid leukemia aml. Nk cells in cancer patients do not work well to fight cancer. Clinical trials are research studies that involve people. This type of treatment which is currently experimental seeks to enhance the cancer fighting power of nk cells.

Researchers in toronto canada at the princess margaret cancer centre ran a phase i clinical trial for 12 patients who had completed stem cell transplant and had either relapsed multiple myeloma or hodgkins lymphoma. These cells were processed based on a novel method for ex vivo activation and expansion using an irradiated and activated autologous feeder cell system. In this review we address strategies developed to circumvent limitations to clinical application of nk cell based therapies and comprehensively review the design and results of clinical trials conducted in the past 10 years 2008 2018 to test their therapeutic potential. Mg4101 has anti tumor activities against various tumors including malignant lymphomas in vitro as well as in vivo tumor model.

All trials on the list are supported by nci.